Chamber and committees

Funding is provided to Local Authorities by means of a block grant to allow them to allocate the total financial resources available to them, on the basis of local needs and priorities, having first fulfilled their statutory obligations and the jointly agreed set of national and local priorities.

It is the responsibility of individual local authorities to manage their own budgets and to allocate the total financial resources available to them, including on additional support needs.

Scottish Government and COSLA work in partnership on additional support needs through the Additional Support for Learning Project Board. The new Education and Childcare Assurance Board provides a further opportunity for jointly agreeing priorities and joint working in this context.

The Scottish Government has no role in reviewing how additional support needs team allocations are determined within local authority secondary schools.

The Education (Additional Support for Learning) (Scotland) Act (2004) places duties on Education authorities to identify, make provision for, and review provision for the additional support needs of children and young people for whose education they are responsible.

Funding is provided to Local Authorities by means of a block grant to allow them to allocate the total financial resources available to them, on the basis of local needs and priorities, having first fulfilled their statutory obligations and the jointly agreed set of national and local priorities.

I refer the member to the answer provided in S6W-38036 on 13 June 2025. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

We have established the National Oncology Coordination Group to provide a coordinated and collaborative response to immediate and foreseeable service pressures. This group provides rapid real-time assessment of highest risk services and proactively develops risk mitigation proposals, in line with the overall strategic aim for cancer. Officials also meet with Boards’ Cancer Management Teams monthly to identify immediate challenges, explore solutions and share best practice.

The Scottish Government has mobilised an ambitious Oncology Transformation Programme and are working closely with NHS Board and regional leaders from across the country to address longer-term pressures. We have also committed to further funding for Chemotherapy and Acute Oncology services using a phased approach to ensure we build a sustainable workforce. The funding will reach up to £10 million per annum and will support increased regional working, workforce recruitment and maximise capacity across the existing workforce. £6.6 million has been provided in 2025-26 and will support NHS Boards to develop sustainable plans.

The Scottish Government is committed to ensuring that parents and carers are central to shaping the development of Additional Support for Learning (ASL) policy. As part of a wider review of ASL, Ministers will consider this publication and its recommendations in addition to other recent reports, which identify areas for improvement.

I have committed to a cross party roundtable with local government to discuss a wider review of the delivery and support for Additional Support Needs in Scotland’s schools. The scope and detail of the review will be informed by the outcome of the roundtable.

Our inclusive approach to education in Scotland is supported by a broad consensus that all children and young people should receive the support they need to thrive. Since the 2020 Morgan Review of ASL, we have delivered over 50 actions to improve educational experiences for children and young people with additional support needs (ASN), empowering them to become directly involved in decision making, increasing learning opportunities for educators and creating parent support groups.

We will continue to work at pace to deliver the remaining actions by the end of this Parliamentary term, including ensuring that parental voice informs the development of ASL policy.

Scottish Government recognises that diagnosing brain cancer can be challenging as symptoms are wide-ranging and often vague, contributing to presentations in emergency settings. We continue to work with primary care to improve the earlier diagnosis of brain cancers.

A clinical review of the Scottish Referral Guidelines for Suspected Cancer has just concluded to help ensure the right person is on the right pathway at the right time. For the first time, the review has ensured the inclusion of a nationally agreed non-specific symptoms referral guideline, as well as an update to the guidance for urgent referral for suspected brain tumours. Publication of the reviewed guidelines is expected this month.

A new primary care cancer education platform, Gateway C, was launched in April 2024. Gateway C provides tailored information to support earlier cancer diagnosis and enable effective decision-making. This platform is accessible to all primary care clinicians and includes a brain tumour course specifically aimed at assisting the effective assessment and management of patients with a potential brain tumour.

A new National Headache Pathway has also been published by the Centre for Sustainable Delivery. This pathway, based on presentation at General Practice, clearly lists red flag symptoms that indicate the need for urgent and/or emergency assessment to exclude a secondary cause, such as a brain tumour.

The medicines regulatory body, the MHRA, has issued regulatory action on labelling of topical steroids with their potencies, so that prescribers and patients can have informed discussions about the length of treatment of these products and associated risks and benefits.

It is a matter for Health Boards to consider the implementation of any new medicine to meet the needs of their local population. However, in response to concerns raised regarding access to givinostat in Scotland, the Cabinet Secretary has met with the four health boards who provide regional services across Scotland for children and adults with neuromuscular disorders, including Duchenne Muscular Dystrophy (DMD). He has asked them to set out their timelines and approaches to the families who have children with DMD, and this is now underway. In addition, the Chief Pharmaceutical Officer (CPO) has been assured that the consultants have reviewed all those who eligible to ensure fair and equitable access across Scotland.

The Scottish Government collects and publishes data on the total number of diversion from prosecution cases commenced for people aged under 18, this is published in the Justice Social Work Statistics in Scotland: 2023-24 - Part 1.

Over the past five years a total of 3,444 diversion from prosecution cases were started for individuals under 18. However, information on the specific alleged offence in each case is not available.

In partnership with NHS Scotland colleagues, the Scottish Government are developing tools to support GP practices to proactively identify people on topical steroids so that their treatment can be reviewed.